ENVB Enveric Biosciences, Inc.

$1.29 -1.15%

Healthcare · Pharmaceutical Preparations

Enveric Biosciences, Inc. (ENVB) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $5 million. Shares last traded at $1.29, 92.0% below their 52-week high. Over the past year the stock is up 4.9%. ENVB trades at a price-to-earnings ratio of 0.39, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 30.3%, above the peer median of -0.1%. Revenue declined 7.2% year over year.

Market Cap

$5M

Shares Out

3.7M

EPS (TTM)

$-53.55

P/E Ratio

0.39

P/S Ratio

0.12

P/B Ratio

0.94

Dividend / Share

—

Dividend Yield

—

52-Week High

$16.07

52-Week Low

$0.55

Volume

2,802

Avg Vol (3m)

73,907.222

Performance

-22.29%

-36.14%

-34.85%

-75.61%

YTD

-64.99%

+4.88%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

26.16

SMA (50)

$2.58

SMA (200)

$2.99

Price vs SMA50

-50.01%

Price vs SMA200

-56.91%

ATR (14)

$0.27

Financials

Revenue

$40M

Net Income

$12M

Gross Margin

20.4%

Operating Margin

-22.0%

Net Margin

30.3%

Return on Equity

239.1%

Return on Assets

219.1%

Current Ratio

11.67

Debt / Equity

0.15

Revenue Growth (YoY)

-7.2%

Latest reported annual period ending 2019-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-1.08	2026-05-15
FY 2025	$-36.24	2026-03-27
Q3 2025	$-35.74	2025-11-14
Q2 2025	$-2.15	2025-08-14
Q1 2026	$-14.58	2026-05-15
FY 2025	$-228.48	2026-03-27

Full earnings history →

Pharmaceutical Preparations peers

ENVB vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

0.39 / 16.82 med

-98% discount

P/S vs peers

0.12 / 3.54 med

-97% discount

Net margin vs peers

30.3% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.